Results 61 to 70 of about 7,361 (190)

The supplement-drug interaction of quercetin with tamsulosin on vasorelaxation

open access: yes, 2015
The food supplement quercetin is used as self-medication for prostate disorders and is known to induce vasorelaxation. The drug tamsulosin is used in the treatment of benign prostatic hyperplasia.
Jansen, E.H.   +7 more
core   +1 more source

Comparative Analysis of 3‐Year Reintervention Rates for Rezum vs. UroLift: A TriNetX Study

open access: yesInternational Journal of Urology, Volume 33, Issue 7, July 2026.
ABSTRACT Objectives Rezum and UroLift are minimally invasive treatments for benign prostatic hyperplasia (BPH), but long‐term comparative data remain limited. This study compared 3‐year reintervention rates between the two procedures using the TriNetX database.
Yu‐Cheng Lu   +4 more
wiley   +1 more source

Artificial Intelligence for Bone: Theory, Methods, and Applications

open access: yesAdvanced Intelligent Discovery, Volume 2, Issue 3, June 2026.
Advances in artificial intelligence (AI) offer the potential to improve bone research. The current review explores the contributions of AI to pathological study, biomarker discovery, drug design, and clinical diagnosis and prognosis of bone diseases. We envision that AI‐driven methodologies will enable identifying novel targets for drugs discovery. The
Dongfeng Yuan   +3 more
wiley   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1787-1808, June 2026.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale   +5 more
wiley   +1 more source

Perbandingan Efektivitas Kombinasi Mirabegron dengan Tamsulosin dan Monoterapi Tamsulosin dalam Mengatasi Gejala Iritatif pada Pasien Benign Prostatic Hiperplasia (BPH) : Telaah Sistematis dan Meta Analisis

open access: yes, 2021
Background: BPH is the most common benign tumor in men that is very age related. The incidence of BPH continues to increase from about 70% of men over the age of 60 to 90% in men over 80 years.
Nasution, Habib Al Kahfi
core  

A Feasibility Study of the Repurposing of Prazosin to Improve Treatment Outcomes in Men Receiving Radiotherapy for Prostate Cancer (MiniRaP‐00)

open access: yesThe Prostate, Volume 86, Issue 8, Page 891-899, June 2026.
ABSTRACT Background Further work is needed to improve treatment outcomes for prostate cancer (PCa), with the repurposing of the α1‐adrenoreceptor antagonists presenting a potential solution. This feasibility clinical trial presents the first prospective data of the use of an α1‐adrenoreceptor antagonist in men undergoing radiotherapy for PCa.
Liam D. King   +8 more
wiley   +1 more source

TAMSULOSIN OR SOLIFENACIN IN LUTS PATIENTS DUE TO DJ-STENT INSERTION

open access: yesJurnal Urologi Indonesia, 2013
Objective: To evaluate the efficacy of tamsulosin or solifenacin for treatment of Lower Urinary Tract Symptoms (LUTS) due to an indwelling ureteral stent.
Subkhan Subkhan   +3 more
doaj   +1 more source

The development of type 2 diabetes amongst sibling pairs in the South‐South region of Nigeria: The effect of genetics, environment and lifestyle

open access: yesDiabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Introduction Type 2 diabetes is a complex condition with a multifactorial pathogenesis. The pathogenesis is considered to be polygenic due to complex interactions between genetic/epigenetic and environmental factors. The aim of this study is to determine the genetic, environmental and lifestyle factors associated with the development of type 2
Sunny Chinenye   +18 more
wiley   +1 more source

A first case of fixed drug eruption due to Tamsulosin

open access: yes, 2020
Background: Fixed Drug Eruption (FDE) is a drug reaction involving the skin and less commonly the mucosal membranes. Tamsulosin is an alpha-1 adrenergic receptor blocker used to treat benign prostatic hyperplasia.
Nouripour, B.   +4 more
core  

Home - About - Disclaimer - Privacy